Results 151 to 160 of about 846,985 (267)

Nationwide Study on the Cervical Cancer Screening Pathway in Estonia. [PDF]

Int J Cancer
Šavrova A, Jakoby H, Tisler A, Innos K, Maiväli Ü, Jaal J, Uusküla A.   +6 more
europepmc   +1 more source

Decoding the dynamic extracellular matrix in cancer—3D models and bioscaffolds rewire the rules of tumor progression

FEBS Letters, EarlyView.
Cancer progression is regulated by the dynamic matrix code of the tumor microenvironment, which influences cellular behavior and disease development. Importantly, matrix remodeling in three‐dimensional cancer models more accurately reflects in vivo conditions compared to conventional two‐dimensional systems.
Sylvia Mangani, Konstantinos Spanopoulos, Zoi Piperigkou, Nikos K. Karamanos   +3 more
wiley   +1 more source

Organized Lung Cancer Screening of Subjects Occupationally Exposed to Lung Carcinogens: The LUng Cancer Screening Occupational exposure Study Entry Findings. [PDF]

JTO Clin Res Rep
Delva F, Gendarme S, Boudet L, Zysman M, Fuhrman C, Brillet PY, Brochard P, Paris C, Bylicki O, Le Denmat V, Loddé B, Belacel M, Abdessemed N, Despagne M, Jaunas K, Lacourt A, Clin B, Gehanno JF, Laurent F, Dournes G, Mathoulin-Pélissier S, Chouaïd C, Pairon JC.   +22 more
europepmc   +1 more source

Identification of a Shiga toxin A‐derived peptide internalized into Gb3 receptor‐bearing cells via interaction with the Shiga toxin B subunit

FEBS Letters, EarlyView.
The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi, João C. Encarnação, Valeria Napolitano, Grzegorz Dubin, Grzegorz Popowicz, Karl Andersson, U. Helena Danielson   +6 more
wiley   +1 more source

Barriers to Health Care and Cancer Screening.

JAMA Netw Open
Gurayah AA, An A, Kuchakulla M, Morley F, Markowitz DM, Mao J, Davuluri M, Al Awamlh BAH, Nanus DM, Tamimi RM, Kensler KH.   +10 more
europepmc   +1 more source

At what age should people with obesity start colorectal cancer screening? [PDF]

Int J Cancer
Seum T, Mandic M, Safizadeh F, Hoffmeister M, Brenner H.   +4 more
europepmc   +1 more source

Investigating transcription factor dynamics in health and disease using FRAP

FEBS Letters, EarlyView.
FRAP analysis of GFP‐tagged transcription factors reveals how molecular mobility and target engagement change in response to drug treatment. By combining live‐cell imaging, quantitative model fitting, and statistical analysis, this approach uncovers transcription factor dynamics linked to disease mechanisms, providing a powerful framework for ...
Kannan Govindaraj, Carolina Vazquez Garzon, Jose Joaquin Velasco, Janine N. Post   +3 more
wiley   +1 more source

Health Equity After a Colorectal Cancer Screening Program.

JAMA Health Forum
Xiong X, Ng CS, Zhang Y, Liang J, Chow JY, Pang SSL, Du X, Law WL, Leung WK, Leung GM, Quan J.   +10 more
europepmc   +1 more source

Evaluation of NID2 and CDO1 methylation for ovarian cancer screening. [PDF]

Oncol Lett
Wu S, Jin J, Cao Y, He X, Hou Q, Jiang M.   +5 more
europepmc   +1 more source

An epithelial GPR35 isoform supports tumor‐associated transcriptional and metabolic phenotypes

FEBS Letters, EarlyView.
GPR35 generates two functionally distinct isoforms with previously unresolved roles. GPR35‐short mediates immune‐cell chemotaxis, while GPR35‐long is enriched in colorectal cancer epithelium, where it supports increased metabolism, proliferation, and tumor‐associated transcriptional programs.
Jørgen D. Rønneberg, Martine Hjeltnes, Josephine Krieger, Joshua E. Elias, Maria Stensland, Kristian Holm, Xiaojun Jiang, Chuki Khangsar, Tuula A. Nyman, Arthur Kaser, Johannes R. Hov, Tom H. Karlsen, Nicole C. Kaneider, Frode L. Jahnsen, Georg Schneditz   +14 more
wiley   +1 more source